Thu, Jul 31, 2014, 10:26 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Astex Pharmaceuticals, Inc. Message Board

  • kyjellie kyjellie Feb 25, 2013 5:34 PM Flag

    Bats back

    EU sales of Dacogen in 2012 was $57M. Couple that with 16M last year. They are closing in on the $100M milestone trigger. Total sales of Dacogen:

    USA $225M
    EU $57M

    But dacogen generic is probably on the way.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Is that last comment from the CC? Have not heard it yet.

      Max

      • 1 Reply to maximus06906
      • The CFO discussed these numbers. Based ion them, I can tell you exactly what the 1Q numbers will be. Revenues will come in at $22.8M.

        Dacogen should still grow in the EU and trigger a $5M milestone at least next year. They also mention that Japan is still in the cards and that would be a 10 year market exclusivity. This is the first time that they have actually discussed Japan. Milestones for Japan are in the range of $17M.

        Hopefully Eisai has plans to go forward there. they definitely have the connections.

        There is no pediatrics patent extension. I believe we see the low $2's again. I did sell some at $3.30 range. So I'll wait to see how the street.

        My best guess at impact of generic:

        The USA will still have nearly $175M in dacogen sales, I figure EU with $60M.

        We are back to 2011 revenues.

        Sentiment: Hold

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.